Walleye Trading LLC Novo Cure LTD Put Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Put Options

24 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $27,825 - $39,450	2,500 Added 113.64%	4,700 $70,000
Q3 2023 Nov 14, 2023	BUY	$16.15 - $42.35 $35,530 - $93,170	2,200 New	2,200 $35,000
Q1 2023 May 15, 2023	BUY	$56.44 - $118.81 $3.32 Million - $7 Million	58,900 Added 806.85%	66,200 $3.98 Million
Q4 2022 Feb 14, 2023	SELL	$63.98 - $85.37 $319,900 - $426,850	-5,000 Reduced 40.65%	7,300 $535,000
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $265,161 - $349,323	3,900 Added 46.43%	12,300 $935,000
Q2 2022 Aug 08, 2022	SELL	$56.6 - $89.9 $622,600 - $988,900	-11,000 Reduced 56.7%	8,400 $584,000
Q1 2022 May 16, 2022	BUY	$60.15 - $84.52 $42,105 - $59,164	700 Added 3.74%	19,400 $1.61 Million
Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $307,828 - $500,159	-4,100 Reduced 17.98%	18,700 $1.4 Million
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $1.88 Million - $3.15 Million	16,200 Added 245.45%	22,800 $2.65 Million
Q2 2021 Aug 16, 2021	BUY	$130.4 - $225.58 $782,400 - $1.35 Million	6,000 Added 1000.0%	6,600 $1.46 Million
Q1 2021 May 17, 2021	SELL	$124.11 - $190.17 $5.93 Million - $9.09 Million	-47,800 Reduced 98.76%	600 $79,000
Q4 2020 Feb 16, 2021	SELL	$112.16 - $174.14 $5.43 Million - $8.43 Million	-48,400 Reduced 50.0%	48,400 $8.38 Million
Q3 2020 Nov 16, 2020	BUY	$58.05 - $111.31 $5.07 Million - $9.73 Million	87,400 Added 929.79%	96,800 $10.8 Million
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $143,000 - $186,025	2,500 Added 36.23%	9,400 $557,000
Q1 2020 May 15, 2020	BUY	$57.05 - $95.75 $165,445 - $277,675	2,900 Added 72.5%	6,900 $465,000
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $122,940 - $168,840	-1,800 Reduced 31.03%	4,000 $337,000
Q3 2019 Nov 14, 2019	SELL	$61.86 - $97.8 $624,786 - $987,780	-10,100 Reduced 63.52%	5,800 $434,000
Q2 2019 Aug 14, 2019	BUY	$42.22 - $63.23 $405,312 - $607,008	9,600 Added 152.38%	15,900 $1.01 Million
Q1 2019 May 15, 2019	SELL	$31.96 - $56.12 $332,384 - $583,648	-10,400 Reduced 62.28%	6,300 $303,000
Q4 2018 Feb 14, 2019	SELL	$28.72 - $52.63 $284,328 - $521,037	-9,900 Reduced 37.22%	16,700 $559,000
Q3 2018 Nov 14, 2018	BUY	$32.0 - $52.4 $812,800 - $1.33 Million	25,400 Added 2116.67%	26,600 $1.39 Million
Q2 2018 Aug 14, 2018	SELL	$19.85 - $32.0 $232,245 - $374,400	-11,700 Reduced 90.7%	1,200 $38,000
Q1 2018 May 15, 2018	BUY	$19.3 - $23.65 $81,060 - $99,330	4,200 Added 48.28%	12,900 $281,000
Q4 2017 Feb 14, 2018	BUY	$16.3 - $21.9 $141,810 - $190,530	8,700	8,700 $175,000

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$352 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$344 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$230 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$125 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$87.9 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.04B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account